These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29141200)

  • 1. Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite.
    Goswami DG; Agarwal R; Tewari-Singh N
    Toxicol Lett; 2018 Sep; 293():112-119. PubMed ID: 29141200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal Exposure to Vesicating Nettle Agent Phosgene Oxime: Clinically Relevant Biomarkers and Skin Injury Progression in Murine Models.
    Goswami DG; Singh SK; Okoyeocha EOM; Roney AK; Madadgar O; Tuttle R; Sosna W; Anantharam P; Croutch CR; Agarwal R; Tewari-Singh N
    J Pharmacol Exp Ther; 2024 Jan; 388(2):536-545. PubMed ID: 37652710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosgene oxime: a highly toxic urticant and emerging chemical threat.
    Singh SK; Klein JA; Wright HN; Tewari-Singh N
    Toxicol Mech Methods; 2021 May; 31(4):288-292. PubMed ID: 33297803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous exposure to vesicant phosgene oxime: Acute effects on the skin and systemic toxicity.
    Tewari-Singh N; Goswami DG; Kant R; Croutch CR; Casillas RP; Orlicky DJ; Agarwal R
    Toxicol Appl Pharmacol; 2017 Feb; 317():25-32. PubMed ID: 28087322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of neutralized chemical agent identification sets (CAIS) for skin injury with an overview of the vesicant potential of agent degradation products.
    Olajos EJ; Olson CT; Salem H; Singer AW; Hayes TL; Menton RG; Miller TL; Rosso T; MacIver B
    J Appl Toxicol; 1998; 18(6):409-20. PubMed ID: 9840748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicants.
    McManus J; Huebner K
    Crit Care Clin; 2005 Oct; 21(4):707-18, vi. PubMed ID: 16168310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible immediate and long-term health effects following exposure to chemical warfare agents.
    Karalliedde L; Wheeler H; Maclehose R; Murray V
    Public Health; 2000 Jul; 114(4):238-48. PubMed ID: 10962584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and environmental hazards associated with exposure to chemical warfare agents: arsenicals.
    Li C; Srivastava RK; Athar M
    Ann N Y Acad Sci; 2016 Aug; 1378(1):143-157. PubMed ID: 27636894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sea-dumped chemical weapons: environmental risk, occupational hazard.
    Greenberg MI; Sexton KJ; Vearrier D
    Clin Toxicol (Phila); 2016; 54(2):79-91. PubMed ID: 26692048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supporting discovery and development of medical countermeasures for chemical injury to eye and skin.
    Araj H; Tseng H; Yeung DT
    Exp Eye Res; 2022 Aug; 221():109156. PubMed ID: 35716762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning.
    Balali-Mood M; Hefazi M
    Fundam Clin Pharmacol; 2005 Jun; 19(3):297-315. PubMed ID: 15910653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSP90, a Common Therapeutic Target for Suppressing Skin Injury Caused by Exposure to Chemically Diverse Classes of Blistering Agents.
    Srivastava RK; Muzaffar S; Khan J; Crossman DK; Agarwal A; Athar M
    J Pharmacol Exp Ther; 2024 Jan; 388(2):546-559. PubMed ID: 37914412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous and systemic toxicology of vesicants used in warfare].
    Pita R; Vidal-Asensi S
    Actas Dermosifiliogr; 2010; 101(1):7-18. PubMed ID: 20109388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure.
    Tewari-Singh N; Agarwal R
    Ann N Y Acad Sci; 2016 Jun; 1374(1):184-92. PubMed ID: 27326543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of vesicant agents scheduled for destruction by the Chemical Stockpile Disposal Program.
    Watson AP; Griffin GD
    Environ Health Perspect; 1992 Nov; 98():259-80. PubMed ID: 1486858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.
    Shakarjian MP; Heck DE; Gray JP; Sinko PJ; Gordon MK; Casillas RP; Heindel ND; Gerecke DR; Laskin DL; Laskin JD
    Toxicol Sci; 2010 Mar; 114(1):5-19. PubMed ID: 19833738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical defense against blistering chemical warfare agents.
    Smith WJ; Dunn MA
    Arch Dermatol; 1991 Aug; 127(8):1207-13. PubMed ID: 1863081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mustard Gas Inhalation Injury: Therapeutic Strategy.
    Keyser BM; Andres DK; Holmes WW; Paradiso D; Appell A; Letukas VA; Benton B; Clark OE; Gao X; Ray P; Anderson DR; Ray R
    Int J Toxicol; 2014 Jul; 33(4):271-281. PubMed ID: 24801489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants.
    Wormser U; Brodsky B; Green BS; Arad-Yellin R; Nyska A
    Arch Toxicol; 1997; 71(3):165-70. PubMed ID: 9049053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blaptica dubia as sentinels for exposure to chemical warfare agents - a pilot study.
    Worek F; Seeger T; Neumaier K; Wille T; Thiermann H
    Toxicol Lett; 2016 Nov; 262():12-16. PubMed ID: 27639501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.